ArticleFrontiers in medicine2026
Blood inflammatory markers combined with tumor markers for differentiating benign prostatic hyperplasia from prostate cancer.
Zeqiang Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it